BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28826178)

  • 1. The Effects of Cortical Hypometabolism and Hippocampal Atrophy on Clinical Trajectories in Mild Cognitive Impairment with Suspected Non-Alzheimer's Pathology: A Brief Report.
    Chung JK; Plitman E; Nakajima S; Caravaggio F; Shinagawa S; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Patel R; Chakravarty MM; Strafella A; Graff-Guerrero A;
    J Alzheimers Dis; 2017; 60(2):341-347. PubMed ID: 28826178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippocampal and Clinical Trajectories of Mild Cognitive Impairment with Suspected Non-Alzheimer's Disease Pathology.
    Chung JK; Plitman E; Nakajima S; Caravaggio F; Iwata Y; Gerretsen P; Kim J; Takeuchi H; Shinagawa S; Patel R; Chakravarty MM; Graff-Guerrero A;
    J Alzheimers Dis; 2017; 58(3):747-762. PubMed ID: 28505977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal and cortical atrophy in amyloid-negative mild cognitive impairments: comparison with amyloid-positive mild cognitive impairment.
    Ye BS; Seo SW; Kim CH; Jeon S; Kim GH; Noh Y; Cho H; Yoon CW; Kim HJ; Jang EY; Lee J; Kim JH; Chin J; Lee JM; Kim JH; Seong JK; Kim CH; Choe YS; Lee KH; Na DL
    Neurobiol Aging; 2014 Feb; 35(2):291-300. PubMed ID: 24080178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and cognitive trajectories in cognitively healthy elderly individuals with suspected non-Alzheimer's disease pathophysiology (SNAP) or Alzheimer's disease pathology: a longitudinal study.
    Burnham SC; Bourgeat P; Doré V; Savage G; Brown B; Laws S; Maruff P; Salvado O; Ames D; Martins RN; Masters CL; Rowe CC; Villemagne VL;
    Lancet Neurol; 2016 Sep; 15(10):1044-53. PubMed ID: 27450471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.
    Hanseeuw B; Dricot L; Lhommel R; Quenon L; Ivanoiu A
    J Alzheimers Dis; 2016 May; 53(2):651-60. PubMed ID: 27232217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depressive Symptoms and Small Hippocampal Volume Accelerate the Progression to Dementia from Mild Cognitive Impairment.
    Chung JK; Plitman E; Nakajima S; Chakravarty MM; Caravaggio F; Takeuchi H; Gerretsen P; Iwata Y; Patel R; Mulsant BH; Graff-Guerrero A
    J Alzheimers Dis; 2016; 49(3):743-54. PubMed ID: 26519442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between visual association memory test and structural changes in patients with Alzheimer's disease and amnestic mild cognitive impairment.
    Huang KL; Hsiao IT; Kuo HC; Hsieh CJ; Hsieh YC; Wu YM; Wey SP; Yen TC; Lin KJ; Huang CC
    J Formos Med Assoc; 2019 Sep; 118(9):1325-1332. PubMed ID: 30579663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment.
    Tomadesso C; Perrotin A; Mutlu J; Mézenge F; Landeau B; Egret S; de la Sayette V; Jonin PY; Eustache F; Desgranges B; Chételat G
    Neuroimage Clin; 2015; 8():473-82. PubMed ID: 26106572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of hippocampal atrophy differ among Alzheimer's disease, amnestic mild cognitive impairment, and late-life depression.
    Joko T; Washizuka S; Sasayama D; Inuzuka S; Ogihara T; Yasaki T; Hagiwara T; Sugiyama N; Takahashi T; Kaneko T; Hanihara T; Amano N
    Psychogeriatrics; 2016 Nov; 16(6):355-361. PubMed ID: 26756596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment.
    Jeon SY; Yi D; Byun MS; Choi HJ; Kim HJ; Lee JH; Baek H; Choe YM; Lee Y; Woo JI; Lee DY
    Neurosci Lett; 2016 Oct; 632():104-8. PubMed ID: 27574728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased hippocampal metabolism in high-amyloid mild cognitive impairment.
    Hanseeuw BJ; Schultz AP; Betensky RA; Sperling RA; Johnson KA
    Alzheimers Dement; 2016 Dec; 12(12):1288-1296. PubMed ID: 27421609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.
    Huijbers W; Mormino EC; Schultz AP; Wigman S; Ward AM; Larvie M; Amariglio RE; Marshall GA; Rentz DM; Johnson KA; Sperling RA
    Brain; 2015 Apr; 138(Pt 4):1023-35. PubMed ID: 25678559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defining SNAP by cross-sectional and longitudinal definitions of neurodegeneration.
    Wisse LEM; Das SR; Davatzikos C; Dickerson BC; Xie SX; Yushkevich PA; Wolk DA;
    Neuroimage Clin; 2018; 18():407-412. PubMed ID: 29487798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspected non-AD pathology in mild cognitive impairment.
    Wisse LEM; Butala N; Das SR; Davatzikos C; Dickerson BC; Vaishnavi SN; Yushkevich PA; Wolk DA;
    Neurobiol Aging; 2015 Dec; 36(12):3152-3162. PubMed ID: 26422359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilizing semantic intrusions to identify amyloid positivity in mild cognitive impairment.
    Loewenstein DA; Curiel RE; DeKosky S; Bauer RM; Rosselli M; Guinjoan SM; Adjouadi M; Peñate A; Barker WW; Goenaga S; Golde T; Greig-Custo MT; Hanson KS; Li C; Lizarraga G; Marsiske M; Duara R
    Neurology; 2018 Sep; 91(10):e976-e984. PubMed ID: 30076274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a specific memory signature associated with Aβ-PET positivity in patients with amnestic mild cognitive impairment?
    Tomadesso C; Gonneaud J; Egret S; Perrotin A; Pélerin A; de Flores R; de la Sayette V; Desgranges B; Chételat G; La Joie R
    Neurobiol Aging; 2019 May; 77():94-103. PubMed ID: 30784816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderly.
    Zhang L; Mak E; Reilhac A; Shim HY; Ng KK; Ong MQW; Ji F; Chong EJY; Xu X; Wong ZX; Stephenson MC; Venketasubramanian N; Tan BY; O'Brien JT; Zhou JH; Chen CLH;
    Hum Brain Mapp; 2020 Jun; 41(8):2037-2047. PubMed ID: 31944479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolution of brain atrophy subtypes during aging predicts long-term cognitive decline and future Alzheimer's clinical syndrome.
    Planche V; Coupé P; Helmer C; Le Goff M; Amieva H; Tison F; Dartigues JF; Catheline G
    Neurobiol Aging; 2019 Jul; 79():22-29. PubMed ID: 31026619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
    Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
    Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.